Ozempic-maker Novo Nordisk A/S is planning to make more of its medicines for the US market in the country; Boeing Co. risks a gummed up supply chain and higher aircraft costs it may not be able to pass on; Chinese online retailer Shein Group Ltd. is offering incentives to its top apparel providers to set up new production capacity in Vietnam.
Trump's $1.4 trillion tariff threats are prompting companies worldwide to seek ways to mitigate potential impacts on sales, profits, and market shares. Many are forming "tariff task forces" to address the challenges. While some companies plan to pass increased costs to consumers, others face potential earnings losses and supply chain disruptions. The tariffs aim to incentivize domestic production, but industrial groups warn of lengthy project timelines.
